Study of CD19 CAR-T Therapy for Refractory SLE

Clinical trial NCT07403097 · RECRUITING

Trial details

NCT number: NCT07403097
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2026-02-01
Primary completion: 2028-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.